A Phase 1 Study to Evaluate a BCG Challenge Model as a Method of Assessing Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A, Alone and in Combination.
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2013
At a glance
- Drugs MVA 85A (Primary) ; BCG vaccine
- Indications Tuberculosis
- Focus Pharmacodynamics
- 01 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2010 New trial record